Hovakim Zakaryan

Hovakim Zakaryan is the co-founder and CEO of Denovo Sciences, a techbio company pioneering AI-driven small molecule drug discovery. With a background in virology and molecular biology, he leads the development of a proprietary platform that generates novel drug-like compounds using synthetic data. Hovakim has experience in antiviral research, computational chemistry, and business development, bridging cutting-edge science with strategic growth. He actively collaborates with academic and industry partners to accelerate antiviral therapeutics discovery globally.

‍